Trump pressured AstraZeneca on US drug prices
Exclusive investigation reveals how Donald Trump pressured AstraZeneca to slash US drug prices while keeping UK costs high, exposing stark transatlantic healthcare divide.
Exclusive investigation reveals how Donald Trump pressured AstraZeneca to slash US drug prices while keeping UK costs high, exposing stark transatlantic healthcare divide.
Former US President Donald Trump makes explosive allegations about pharmaceutical companies exploiting the NHS during pandemic negotiations, claiming Britain paid 'far more than other countries' for COVID vaccines.
Indian authorities have detained three pharmaceutical executives following an investigation into contaminated cough syrup allegedly responsible for numerous child deaths in Cameroon.
Exclusive investigation reveals Donald Trump's plans to put NHS on the table in US trade negotiations, raising alarm about drug prices and American corporate influence on Britain's healthcare system.
Exclusive investigation reveals how potential Trump tariffs could devastate NHS medicine budgets while pharmaceutical giants reconsider UK investments over pricing disputes.
Pharmaceutical giants are launching an unprecedented legal assault against the UK government, threatening NHS access to vital medicines and putting patient care at risk in a battle over drug pricing.
Exclusive investigation reveals how drug companies are profiting from body shame through Ozempic and Wegovy injections, while eating disorder experts warn of potentially devastating health consequences.
Pharmaceutical giant Kenvue has issued a stern rebuke to Donald Trump after he suggested the COVID-19 vaccine was comparable to the Tylenol murders, calling the analogy 'irresponsible'.
Exclusive investigation into the rapid rise of corporate co-living spaces in New York City. Are these 'pod' apartments providing affordable solutions or accelerating displacement in already vulnerable communities? We examine the stark reality behind the t
UK politicians are calling for urgent reform of Companies House after it was revealed the Blackburn Labour Party was wrongly listed as a person of significant control for dozens of dormant firms, exposing a major flaw in the corporate register.
A senior Chinese pharmaceutical executive has been sentenced to 15 years in a US prison for conspiring to manufacture and distribute fentanyl, marking a significant victory in the transatlantic fight against the opioid crisis.
Exclusive analysis reveals a personal debt crisis gripping Britain, with Wales recording the highest rate of insolvency procedures in England and Wales. Discover the regional hotspots and the alarming 15% annual surge in IVAs.
Ex-Labour leader Jeremy Corbyn faces potential suspension from Parliament after registering 'The Jeremy Corbyn Peace and Justice Project' as a political party, triggering a parliamentary standards investigation.
Exclusive insight into how NHS England's shrewd negotiation tactics secure massive discounts on vital medicines, from cancer treatments to rare disease drugs, ensuring sustainable healthcare funding.
Normal People author Sally Rooney has publicly endorsed Palestine Action, the direct-action group targeting Israeli defence company Elbit Systems' UK operations. The literary star's support signals growing cultural backing for the movement.
Green Party co-leader Adrian Ramsay blames decades of privatisation for soaring bills and calls for public ownership of energy and rail. Expert insights and political reactions inside.
Nottingham-based Games Workshop enjoys stock boost as Federal Reserve holds interest rates, sparking global market rally and boosting UK retail investments.
An explosive investigation by determined citizen scientists reveals how systemic sewage dumping by water companies is causing the slow, dirty death of rivers across England and Wales, with regulators accused of turning a blind eye.
Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.
Former chief scientific adviser Sir Patrick Vallance warns that dwindling investment in medical research and innovation threatens the future of the NHS and patient care. Discover the urgent call for action.
Pharmaceutical giant Merck to manufacture flagship cancer drug Lynparza at new €1 billion Irish facility, dealing significant blow to UK's life sciences sector and raising fresh post-Brexit trade concerns.
British motorists are facing a record onslaught of private parking tickets, with a shocking 24% annual surge in charges. Discover the data behind the £100M industry and how to fight back.
Exclusive analysis reveals how a potential Trump presidency could jeopardise Britain's NHS medicine pricing, forcing UK patients to pay US-style pharmaceutical costs.
Shocking new data reveals sewage was pumped into the rivers and lakes of Britain's most treasured national parks for thousands of hours last year, with the Lake District and Snowdonia among the worst hit.
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
A damning report reveals UK companies are failing bereaved customers, with families harassed for payments and forced through complex 'death admin' while grieving.
Exclusive: Troubled utility giant Thames Water paid over £1 million to a corporate intelligence firm co-owned by a key adviser to Keir Starmer, raising serious questions about conflicts of interest and corporate governance.
Pharmaceutical giant AstraZeneca has paused plans for its new £500 million global headquarters in Cambridge, citing an 'unfavourable' UK economic climate and sending shockwaves through the business community.
In a major environmental policy reversal, the Trump administration has abolished a mandate requiring large US companies to disclose their greenhouse gas emissions. Critics warn this decision blindsides investors and undermines global climate efforts.
An explosive legal dispute has laid bare former Labour minister Lord Mandelson's relentless pursuit of wealth, revealing a life of luxury funded by a complex web of offshore dealings and multi-million pound loans.